Podcast Episodes
Back to Search
Avoiding Commercialization Pitfalls for CGTs
Commercialization is a tough road to navigate even for the most established bio/pharmaceutical therapies. But as cell and gene therapies (CGTs) conti…
2 years, 10 months ago
Ethical AI Practices
Gerald Kierce, co founder and CEO of Trustible and Andrew Gamino-Cheong, the company's CTO and co founder, delve into the realm of artificial intelli…
2 years, 10 months ago
Drug Pricing Challenges and Navigating The IRA
How to price a bio/pharmaceutical drug is one of the most complex topics for pharmaceutical executives, as there are many factors to consider. Alice …
2 years, 10 months ago
Pharma Marketing in the Age of AI: A New Era Begins
In this podcast, Sharlene Jenner, vice president of engagement strategy at Abelson Taylor and professor of AI and personalization for digital markete…
2 years, 11 months ago
Transforming Cancer Care: Data, AI, and Patient-Centered Care
In this podcast, Mohit Manrao, the SVP and head of US oncology at AstraZeneca, shares his journey from growing up in Northern India with aspirations …
2 years, 11 months ago
AI Frontiers: Navigating the Risks, Rewards, and Regulations
Welcome to a riveting episode of the Pharm Exec podcast, where we dive headfirst into the transformative world of AI in healthcare with Sharlene Jenn…
3 years ago
Listening is the Key to Good Leadership
We all know that the pharma industry is about people—bettering the lives of others through good research, life-changing pharmaceuticals, and keeping …
3 years ago
The Trust Imperative: Defining and Building Trust in Pharma
This Pharma 50 companion episode delves into the vital topic of trust within the pharmaceutical industry. Morton Nielsen, senior partner for the life…
3 years, 1 month ago
Emerging Potential: Changing Lives One Story, One Therapeutic at a Time
The 2023 Emerging Pharma Leaders share with Meg Rivers, managing editor of Pharmaceutical Executive, and the editorial team what makes a good leader,…
3 years, 1 month ago
Drug Approvals And Launches From A Legal Perspective
Launching a drug and receiving approvals—whether it’s in the U.S. or globally—is challenging to navigate. It’s a process that often takes years and a…
3 years, 2 months ago